{"Thioguanine can be affected by a patient's TPMT and NUDT15 phenotype. This patient is predicted to be a TPMT normal metabolizer. Based on that specific result, the patient may receive a standard starting dose of thioguanine. However, NUDT15 status could not be determined based on genotyping performed. If thioguanine is required and NUDT15 status is unknown, monitor closely for toxicity. Please consult a clinical pharmacist for more information."}